DEFINITIVE PROXY STATEMENT

Company

Lexaria Bioscience Corp.

Filed

May 13, 2011

Period of Report

June 17, 2011

Accession Number

0001204459-11-001349

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →